advanced GC/GEJQ-1802OxaliplatinPeking University Cancer HospitalXELOXcapecitabine
…se I/II clinical trial (Qure-1802-201). Patients with untreated advanced GC/GEJ are administered with Q-1802 (IV, Q2W) respectively at 10 mg/kg…
1articles mentioning diseases
3disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: advanced GC/GEJ ×
advanced GC/GEJ
This disease is selected. Its supporting articles are shown below.